Hainan Haiyao Co., Ltd. (SHE:000566)
6.34
+0.13 (2.09%)
Feb 24, 2026, 3:04 PM CST
Hainan Haiyao Revenue
Hainan Haiyao had revenue of 189.41M CNY in the quarter ending September 30, 2025, a decrease of -10.36%. This brings the company's revenue in the last twelve months to 825.66M, down -19.89% year-over-year. In the year 2024, Hainan Haiyao had annual revenue of 990.70M, down -33.00%.
Revenue (ttm)
825.66M
Revenue Growth
-19.89%
P/S Ratio
9.96
Revenue / Employee
412.21K
Employees
2,003
Market Cap
8.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 990.70M | -487.88M | -33.00% |
| Dec 31, 2023 | 1.48B | -300.47M | -16.89% |
| Jan 1, 2023 | 1.78B | -280.01M | -13.60% |
| Jan 1, 2022 | 2.06B | -141.25M | -6.42% |
| Dec 31, 2020 | 2.20B | -244.98M | -10.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Animal Husbandry Industry | 6.28B |
| Renhe Pharmacy Co.,Ltd | 3.76B |
| Cisen Pharmaceutical | 3.56B |
| Jiangsu Kanion Pharmaceutical | 3.13B |
| Guangxi Wuzhou Zhongheng Group | 2.29B |
| Sunflower Pharmaceutical Group Co.,Ltd | 2.09B |
| Hubei Hongyuan Pharmaceutical Technology | 1.77B |
| Sichuan Huiyu Pharmaceutical | 984.29M |